-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cardio Diagnostics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q2 2025.
- Cardio Diagnostics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 1.74M shares, a 131% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 26.9M shares, a 112% increase from 2023.
- Cardio Diagnostics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 12.7M shares, a 311% increase from 2022.
- Cardio Diagnostics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.09M shares, a 165% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)